Publications internationales
Nous mettons ici à votre disposition une sélection de publications scientifiques en rapport avec l'immunothérapie IOZK.
Vous pouvez effectuer une sélection par type de tumeur et par méthode à l'aide des filtres ou saisir des termes de recherche.
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy
Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro
Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
Activation of dendritic cells by local ablation of hepatocellular carcinoma
Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma
Natural-killer cells and dendritic cells: „l’union fait la force“
Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]
Vaccine therapy for non-Hodgkin’s lymphoma and other B-cell malignancies
[Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma]
[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte]
Chaperone-rich cell lysates, immune activation and tumor vaccination